1. Home
  2. FAMI vs GLMD Comparison

FAMI vs GLMD Comparison

Compare FAMI & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

BUY

Current Price

$1.44

Market Cap

7.8M

ML Signal

BUY

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

HOLD

Current Price

$0.80

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
GLMD
Founded
2015
2000
Country
China
Israel
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
6.6M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
FAMI
GLMD
Price
$1.44
$0.80
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
600.1K
82.7K
Earning Date
08-04-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,831,754.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.73
52 Week High
$3.64
$3.50

Technical Indicators

Market Signals
Indicator
FAMI
GLMD
Relative Strength Index (RSI) 55.87 42.18
Support Level $1.11 $0.76
Resistance Level $1.43 $0.88
Average True Range (ATR) 0.14 0.05
MACD 0.02 0.01
Stochastic Oscillator 79.09 54.60

Price Performance

Historical Comparison
FAMI
GLMD

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Share on Social Networks: